Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
2373
mi
from 98109
Bennington, VT
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
2373
mi
from 98109
Bennington, VT
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
2351
mi
from 98109
Richmond, VA
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
2351
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
1684
mi
from 98109
Milwaukee, WI
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
1684
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
967
mi
from 98109
Los Angeles, CA
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
967
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 2
964
mi
from 98109
Los Angeles, CA
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 2
964
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #3
mi
from 98109
Los Angeles, CA
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #3
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #1
mi
from 98109
Boca Raton, FL
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #1
mi
from 98109
Boca Raton, FL
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #2
mi
from 98109
Boca Raton, FL
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #2
mi
from 98109
Boca Raton, FL
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
2720
mi
from 98109
Hallandale Beach, FL
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
2720
mi
from 98109
Hallandale Beach, FL
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #1
mi
from 98109
Leesburg, FL
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #1
mi
from 98109
Leesburg, FL
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #2
mi
from 98109
Leesburg, FL
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #2
mi
from 98109
Leesburg, FL
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #1
mi
from 98109
Naples, FL
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #1
mi
from 98109
Naples, FL
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
2527
mi
from 98109
Saint Petersburg, FL
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
2527
mi
from 98109
Saint Petersburg, FL
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
2527
mi
from 98109
Tampa, FL
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
2479
mi
from 98109
Newton, MA
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
2479
mi
from 98109
Newton, MA
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
1852
mi
from 98109
Lansing, MI
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
1852
mi
from 98109
Lansing, MI
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #1
mi
from 98109
West Bloomfield, MI
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #1
mi
from 98109
West Bloomfield, MI
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility 1
1719
mi
from 98109
Saint Louis, MO
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility 1
1719
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #2
2400
mi
from 98109
New York, NY
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #2
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #1
2370
mi
from 98109
Jenkintown, PA
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #1
2370
mi
from 98109
Jenkintown, PA
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #2
1787
mi
from 98109
San Antonio, TX
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #2
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Facility #1
mi
from 98109
Kentville,
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Facility #1
mi
from 98109
Kentville,
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
1115
mi
from 98109
Phoenix, AZ
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
1115
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine
995
mi
from 98109
Irvine, CA
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine
995
mi
from 98109
Irvine, CA
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
2432
mi
from 98109
New Haven, CT
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
2457
mi
from 98109
Jacksonville, FL
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
2457
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Indiana University
1866
mi
from 98109
Indianapolis, IN
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Indiana University
1866
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
2005
mi
from 98109
Lexington, KY
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
2005
mi
from 98109
Lexington, KY
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
2326
mi
from 98109
Baltimore, MD
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
2326
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
2279
mi
from 98109
Winston-Salem, NC
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
2279
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University
2030
mi
from 98109
Beachwood, OH
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University
2030
mi
from 98109
Beachwood, OH
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
2486
mi
from 98109
Providence, RI
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
2486
mi
from 98109
Providence, RI
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Roper St. Francis Hospital
2424
mi
from 98109
Charleston, SC
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Roper St. Francis Hospital
2424
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
U of WA / VA Puget Sound Alzheimer's Disease Research Center
6
mi
from 98109
Seattle, WA
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
U of WA / VA Puget Sound Alzheimer's Disease Research Center
6
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai School of Medicine
2402
mi
from 98109
New York, NY
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai School of Medicine
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Barrow Neurology Clinics
1114
mi
from 98109
Phoenix, AZ
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Barrow Neurology Clinics
1114
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Emory University
2178
mi
from 98109
Atlanta, GA
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Emory University
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
2485
mi
from 98109
Boston, MA
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Tulsa Clinical Research
1560
mi
from 98109
Tulsa, OK
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Tulsa Clinical Research
1560
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Georgetown University
2322
mi
from 98109
Washington,
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Georgetown University
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated:  12/31/1969
Howard University
2322
mi
from 98109
Washington,
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Status: Enrolling
Updated: 12/31/1969
Howard University
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers
"[11C] PIB Comparison Study to [18F] AV-45 in Subjects With Alzheimer's Disease (AD) and Age Matched Healthy Controls"
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Medical Institution- Dept of Radiology , Division of Nuclear Medicine
2329
mi
from 98109
Baltimore, MD
PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers
"[11C] PIB Comparison Study to [18F] AV-45 in Subjects With Alzheimer's Disease (AD) and Age Matched Healthy Controls"
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Medical Institution- Dept of Radiology , Division of Nuclear Medicine
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes
Early Markers of Alzheimer's Disease in BLSA Participants: Structural and Functional Brain Changes
Status: Enrolling
Updated:  12/31/1969
National Institute of Aging, Clinical Research Unit
2331
mi
from 98109
Baltimore, MD
Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes
Early Markers of Alzheimer's Disease in BLSA Participants: Structural and Functional Brain Changes
Status: Enrolling
Updated: 12/31/1969
National Institute of Aging, Clinical Research Unit
2331
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes
Early Markers of Alzheimer's Disease in BLSA Participants: Structural and Functional Brain Changes
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
2326
mi
from 98109
Baltimore, MD
Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes
Early Markers of Alzheimer's Disease in BLSA Participants: Structural and Functional Brain Changes
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
2326
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials